Establishment of a GIST-T1 gastrointestinal stromal tumour cell line resistant to imatinib mesylate

In the present study, imatinib mesylate (IM) was used to induce resistance in the gastrointestinal stromal tumour (GIST) cell line, GIST-T1, to establish a stable resistant cell line. The growth characteristics and expression profile of the established cell line were compared with those of the paren...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yongjian, Chen, Jiabi, Weng, Xiaoyuan, Lin, Guosheng, Huang, Zicheng, Shui, Hanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934714/
https://www.ncbi.nlm.nih.gov/pubmed/29740484
http://dx.doi.org/10.3892/ol.2018.8283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934714/
https://www.ncbi.nlm.nih.gov/pubmed/29740484
http://dx.doi.org/10.3892/ol.2018.8283

Ejemplares similares